Intra-Cellular Therapies, Inc.
ITCI News Today: Stay Updated with the Latest Intra-Cellular Therapies, Inc. News in Real Time
Find ITCI news now at Meyka AI. Stay informed with the latest Intra-Cellular Therapies, Inc. stocks updates, including price news, market analysis, and expert insights.
February 24: Takaichi Cabinet 2.0 Backs Drug Investment, Biosimilar Parity
Takaichi Cabinet 2.0 backs public-private drug R&D and extends Japan drug pricing reform 2026 to biologics via the G1 rule, moving originator prices toward biosimilar parity. What it means for Japan’s
PEP.SW PepsiCo (SIX) +7.69% to CHF 126.00 Market Closed 23 Feb 2026: Check momentum
PEP.SW stock jumps to CHF 126.00 on a volume spike; Meyka AI flags momentum and issues model forecasts
OCNB hits $32.00 on PNK 23 Feb 2026: low PE and thin volume point to mixed opportunity
OCNB stock jumps to $32.00 on PNK; analysis of PE 1.31, forecasts, and Meyka AI grade
Monness Maintains Sell on COIN Coinbase Global, Inc. Feb 23 2026
Monness kept a Sell on COIN Feb 23, 2026. Read our COIN analyst rating review and investor implications.
Cowen Maintains Hold on Domino’s Pizza, Inc. (DPZ) Feb 2026
DPZ analyst rating: Cowen maintained Hold Feb 23, 2026 and cut price target to $450
Volume spike lifts TICO.CN to C$0.12 (+20%) on 23 Feb 2026 (CNQ): watch short-term momentum
TICO.CN stock jumps 20% to C$0.12 on Feb 23 2026 with 150x volume; analysis, grade and Meyka AI forecast to C$0.24
MEDVF Medivolve Inc. (PNK) $0.002 23 Feb 2026: Oversold bounce signal to watch
MEDVF stock at $0.002 on PNK: oversold bounce thesis, Meyka AI forecast and short-term trade criteria
BTIG Maintains Neutral on OPEN Opendoor Technologies Inc. Feb 23 2026
BTIG kept a Neutral OPEN analyst rating on Feb 23, 2026; implications, context, and Meyka analysis of Opendoor
7226.HK at HK$4.74 pre-market (HKSE) 24 Feb 2026: heavy volume signals volatility
Pre-market note on 7226.HK stock at HK$4.74 with heavy volume and Meyka AI market analysis